Intracoronary antithrombotic therapy during primary percutaneous coronary intervention in patients with STEMI: A systematic review and network meta-analysis

The efficacy of intracoronary (IC) antithrombotic therapy, which may best prevent the no-reflow phenomenon during percutaneous coronary intervention (PCI), remains unclear. Therefore, we compared the efficacy and safety of different IC antithrombotic agents.

Source: Thrombosis Research - November 21, 2023 Category: Hematology Authors: Min Jung Geum, Yun Mi Yu, Jinyoung Jeon, Hyun Woo Lee, Jaekyu Shin, Woo-Young Chung, JongSung Hahn, Young-Mi Ah Source Type: research